Research ArticleClinical Investigation
PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes
Nikil Prasad, Erin Harris, Ersilia M. DeFilippis, Gabriel Sayer, Margarita Chernovolenko, Paolo C. Colombo, Justin Fried, David Bae, Kyung Taek Oh, Jayant Raikhelkar, Sambhavi Sneha Kumar, Melana Yuzefpolskaya, Veli K. Topkara, Michelle Castillo, Elaine Y. Lam, Farhana Latif, Koji Takeda, Nir Uriel, Andrew J. Einstein and Kevin J. Clerkin
Journal of Nuclear Medicine February 2025, 66 (2) 264-270; DOI: https://doi.org/10.2967/jnumed.124.268713
Nikil Prasad
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Erin Harris
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Ersilia M. DeFilippis
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Gabriel Sayer
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Margarita Chernovolenko
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Paolo C. Colombo
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Justin Fried
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
David Bae
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Kyung Taek Oh
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Jayant Raikhelkar
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Sambhavi Sneha Kumar
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Melana Yuzefpolskaya
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Veli K. Topkara
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Michelle Castillo
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Elaine Y. Lam
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Farhana Latif
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Koji Takeda
2Division of Cardiothoracic and Vascular Surgery, Department of Surgery, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York; and
Nir Uriel
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
Andrew J. Einstein
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;
3Department of Radiology, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York
Kevin J. Clerkin
1Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York;

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 2
February 1, 2025
PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes
Nikil Prasad, Erin Harris, Ersilia M. DeFilippis, Gabriel Sayer, Margarita Chernovolenko, Paolo C. Colombo, Justin Fried, David Bae, Kyung Taek Oh, Jayant Raikhelkar, Sambhavi Sneha Kumar, Melana Yuzefpolskaya, Veli K. Topkara, Michelle Castillo, Elaine Y. Lam, Farhana Latif, Koji Takeda, Nir Uriel, Andrew J. Einstein, Kevin J. Clerkin
Journal of Nuclear Medicine Feb 2025, 66 (2) 264-270; DOI: 10.2967/jnumed.124.268713
PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes
Nikil Prasad, Erin Harris, Ersilia M. DeFilippis, Gabriel Sayer, Margarita Chernovolenko, Paolo C. Colombo, Justin Fried, David Bae, Kyung Taek Oh, Jayant Raikhelkar, Sambhavi Sneha Kumar, Melana Yuzefpolskaya, Veli K. Topkara, Michelle Castillo, Elaine Y. Lam, Farhana Latif, Koji Takeda, Nir Uriel, Andrew J. Einstein, Kevin J. Clerkin
Journal of Nuclear Medicine Feb 2025, 66 (2) 264-270; DOI: 10.2967/jnumed.124.268713
Jump to section
Related Articles
Cited By...
- No citing articles found.